We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DPLM:LSEDiploma PLC Analysis

Data as of 2026-06-07 - not real-time

£7,020.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Diploma PLC is trading at £7,020, comfortably above its 20‑day SMA of 6,898.5 and 50‑day SMA of 6,726.8, while still higher than the 200‑day SMA of 5,755.4, confirming a bullish long‑term trend. The RSI of 55.9 indicates modest momentum and the MACD histogram is slightly negative with a bearish signal line, suggesting a near‑term pause as price approaches the resistance level of £7,160. Volatility is elevated at 26.3% (30‑day) but beta is low at 0.25, meaning the stock is less sensitive to market moves yet can swing sharply. Recent earnings delivered a 36% YoY EPS increase and 16.8% revenue growth, sparking a 6% rally and prompting analysts to raise the median target to £7,500. The Fear & Greed Index at 83 (“Extreme Greed”) reflects strong investor enthusiasm.
Despite the momentum, valuation remains stretched: a trailing PE of 49.8 versus an industry average of 30, a price‑to‑book of 8.96×, and a DCF‑derived fair value of only £4,493, indicating the market is pricing a substantial premium. Forward PE improves to 28, and the dividend yield of 0.9% with a 44% payout ratio appears sustainable given solid free cash flow. Debt of £501 m (debt‑to‑equity 47.5%) is manageable against a ROE of 19% and operating cash flow of £284 m. The mix of strong growth fundamentals and high valuation leads to a nuanced outlook: short‑term caution near resistance, medium‑term upside of roughly 7.6%, and a long‑term need for price convergence to fundamentals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price approaching key resistance at £7,160
  • Bearish MACD signal suggesting short‑term pause
  • Elevated volatility but low beta limiting market‑wide swings

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst median target of £7,500 implying ~7.6% upside
  • Strong revenue growth (16.8%) and EPS acceleration (36% YoY)
  • Improving forward PE to 28 and solid free cash flow

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Valuation gap between market price and DCF fair value
  • Sustainable dividend with healthy payout ratio
  • Diversified geographic footprint reducing concentration risk

Key Metrics & Analysis

Financial Health

Revenue Growth16.80%
Profit Margin11.50%
P/E Ratio49.8
ROE18.95%
ROA10.78%
Debt/Equity47.45
P/B Ratio9.0
Op. Cash Flow£283.9M
Free Cash Flow£244.3M
Industry P/E30.2

Technical Analysis

TrendBullish
RSI55.9
Support£6,600.00
Resistance£7,160.00
MA 20£6,898.50
MA 50£6,726.80
MA 200£5,755.43
MACDBearish
VolumeStable
Fear & Greed Index83.02

Valuation

Fair Value£4,492.51
Target Price£7,553.75
Upside/Downside7.60%
GradeOvervalued
TypeBlend
Dividend Yield0.90%

Risk Assessment

Beta0.25
Volatility26.27%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.